Olink Holding AB (publ)
NASDAQ:OLK
P/E
Price to Earnings
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
Market Cap | P/E | ||||
---|---|---|---|---|---|
SE |
Olink Holding AB (publ)
NASDAQ:OLK
|
3B USD | -88.6 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
218.6B USD | 36.2 | ||
US |
Danaher Corp
NYSE:DHR
|
191.6B USD | 23.8 | ||
US |
Agilent Technologies Inc
NYSE:A
|
43.4B USD | 35.1 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
41.3B USD | 30.4 | ||
CH |
Lonza Group AG
SIX:LONN
|
35.7B CHF | 54.6 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
53T KRW | 59.2 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
31.1B USD | 39.9 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
26.5B USD | 38.9 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
23.9B USD | 42 | ||
US |
Waters Corp
NYSE:WAT
|
19.7B USD | 32.6 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.